E-Book

Nasal Delivery Technology, Quality By Design Processes And Outsourcing Considerations

Source: Catalent
GettyImages-1312594792-inhalation-lung

Catalent leverages decades of experience in the development, evaluation and manufacture of inhalation products to advance and accelerate molecules, from early development through commercial manufacturing. Catalent’s operation integrates its knowledge and experience to reliably deliver therapies across all common inhalation dosage forms including MDI, DPI and nasal sprays.

This eBook features articles discussing the advantages of unit/bi-dose nasal delivery technology, application of quality by design (QbD) process for inhaled product development and why companies are looking to outsource inhalation development and manufacturing.

VIEW THE E-BOOK!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: